- Home
- ELMD vs GNLX Comparison
ELMD vs GNLX Comparison
Compare ELMD & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- GNLX
- Stock Information
- Founded
- ELMD 1992
- GNLX 2001
- Country
- ELMD United States
- GNLX United States
- Employees
- ELMD N/A
- GNLX N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- GNLX Health Care
- Exchange
- ELMD Nasdaq
- GNLX Nasdaq
- Market Cap
- ELMD N/A
- GNLX 103.6M
- IPO Year
- ELMD 2010
- GNLX 2023
- Fundamental
- Price
- ELMD $27.73
- GNLX $2.27
- Analyst Decision
- ELMD
- GNLX Strong Buy
- Analyst Count
- ELMD 0
- GNLX 4
- Target Price
- ELMD N/A
- GNLX $18.25
- AVG Volume (30 Days)
- ELMD 94.6K
- GNLX 142.7K
- Earning Date
- ELMD 02-11-2025
- GNLX 11-14-2024
- Dividend Yield
- ELMD N/A
- GNLX N/A
- EPS Growth
- ELMD 94.54
- GNLX N/A
- EPS
- ELMD 0.72
- GNLX N/A
- Revenue
- ELMD $57,060,000.00
- GNLX $8,000.00
- Revenue This Year
- ELMD $14.27
- GNLX N/A
- Revenue Next Year
- ELMD N/A
- GNLX N/A
- P/E Ratio
- ELMD $38.61
- GNLX N/A
- Revenue Growth
- ELMD 14.73
- GNLX N/A
- 52 Week Low
- ELMD $9.81
- GNLX $1.60
- 52 Week High
- ELMD $31.31
- GNLX $16.60
- Technical
- Relative Strength Index (RSI)
- ELMD 48.70
- GNLX 38.68
- Support Level
- ELMD $26.91
- GNLX $2.13
- Resistance Level
- ELMD $28.98
- GNLX $2.80
- Average True Range (ATR)
- ELMD 1.22
- GNLX 0.20
- MACD
- ELMD -0.45
- GNLX -0.04
- Stochastic Oscillator
- ELMD 21.93
- GNLX 14.21
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.